SMAD2 and neoplasm: Notably, the activation of SMAD2/3 represents a critical element in the regulation of TGF-β and SDF-1 autocrine signaling, which is essential for myofibroblast differentiation, phenotype maintenance, and associated tumor-promoting activities [33].